vimarsana.com

Latest Breaking News On - மோரிங்கா கையகப்படுத்தல் - Page 1 : vimarsana.com

Banker claims N Y law firm choked off assets, derailing SPAC profits

A longtime investment banker is accusing a New York law firm of malpractice after it allegedly froze his company's assets and restricted his ability to invest in a special purpose acquisition company he helped launch.

Israeli SPAC Moringa raises $100m on Nasdaq

Israeli SPAC Moringa raises $100m on Nasdaq The special purpose acquisition company will now look for an Israeli tech company to merge into. Israeli special purpose acquisition company (SPAC) Moringa Acquisition Corp. has $100 million on Nasdaq and will now seek an Israeli tech company to merge into. Blank check company Moringa successfully issued 10,000,000 units at $10 per unit and will list on Nasdaq under the MACAU ticker. EarlyBirdCapital Inc. and Moelis & Company acted as joint book-running managers for the offering. They have been granted a 45-day option to purchase up to an additional 1,500,000 units at the initial public offering price. RELATED ARTICLES

Israeli SPAC Moringa files to raise $100m for tech merger

Israeli SPAC Moringa files to raise $100m for tech merger According to its prospectus, the company will focus on mid-size Israel-related technology companies. Israeli special purpose acquisition company (SPAC) Moringa Acquisition Corp. has filed to raise $100 million on Nasdaq for the acquisition of an Israeli tech company. The underwriters are EarlyBirdCapital and Moelis & Co. Moringa is led by chairman and CEO Ilan Levin, a former senior executive at 3D printing firm Stratasys (Nasdaq: SSYS), and vice chairman Craig Marshak, who previously was managing director and global co-head of the Nomura Technology Investment Growth Fund, alongside CFO Gil Maman, who previously served in senior positions at Stratsys and SimilarWeb;

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.